Alerus Financial NA grew its position in shares of Danaher Co. (NYSE:DHR) by 17.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 28,547 shares of the conglomerate’s stock after purchasing an additional 4,261 shares during the period. Alerus Financial NA’s holdings in Danaher were worth $2,794,000 at the end of the most recent reporting period.
Other hedge funds have also recently modified their holdings of the company. Ninepoint Partners LP lifted its stake in Danaher by 1.4% during the fourth quarter. Ninepoint Partners LP now owns 49,700 shares of the conglomerate’s stock worth $4,613,000 after purchasing an additional 700 shares during the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its stake in Danaher by 11.7% during the fourth quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 253,593 shares of the conglomerate’s stock worth $23,539,000 after purchasing an additional 26,584 shares during the last quarter. BancorpSouth Bank bought a new stake in Danaher during the fourth quarter worth about $651,000. MetLife Investment Advisors LLC bought a new stake in Danaher during the fourth quarter worth about $17,580,000. Finally, Kendall Capital Management bought a new stake in Danaher during the fourth quarter worth about $368,000. 76.66% of the stock is owned by hedge funds and other institutional investors.
In related news, Director Linda P. Hefner sold 18,001 shares of the business’s stock in a transaction dated Thursday, April 26th. The stock was sold at an average price of $101.51, for a total transaction of $1,827,281.51. Following the transaction, the director now owns 25,225 shares in the company, valued at approximately $2,560,589.75. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Walter G. Lohr sold 10,578 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $97.90, for a total value of $1,035,586.20. Following the transaction, the director now owns 19,821 shares in the company, valued at approximately $1,940,475.90. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 267,077 shares of company stock worth $27,022,784. 11.90% of the stock is owned by company insiders.
Several equities research analysts have issued reports on the company. Robert W. Baird reaffirmed a “buy” rating and set a $106.00 price target on shares of Danaher in a research note on Friday, April 20th. Jefferies Group reiterated a “buy” rating and issued a $117.00 price objective on shares of Danaher in a report on Friday, April 20th. Credit Suisse Group reiterated an “outperform” rating on shares of Danaher in a report on Friday, March 9th. Stifel Nicolaus reiterated a “buy” rating and issued a $114.00 price objective (up previously from $108.00) on shares of Danaher in a report on Thursday, April 19th. Finally, Morgan Stanley lifted their price objective on Danaher from $103.00 to $110.00 and gave the stock an “overweight” rating in a report on Wednesday, January 31st. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $105.56.
Shares of Danaher opened at $101.41 on Wednesday, Marketbeat Ratings reports. Danaher Co. has a 1 year low of $78.97 and a 1 year high of $104.82. The stock has a market cap of $70.73 billion, a P/E ratio of 25.16, a price-to-earnings-growth ratio of 1.90 and a beta of 1.03. The company has a current ratio of 1.59, a quick ratio of 1.15 and a debt-to-equity ratio of 0.38.
Danaher (NYSE:DHR) last announced its quarterly earnings results on Thursday, April 19th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.05. Danaher had a return on equity of 11.39% and a net margin of 13.56%. The company had revenue of $4.70 billion for the quarter, compared to the consensus estimate of $4.54 billion. During the same quarter in the previous year, the business earned $0.85 EPS. Danaher’s revenue was up 11.6% compared to the same quarter last year. analysts expect that Danaher Co. will post 4.45 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 27th. Investors of record on Friday, June 29th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Thursday, June 28th. This represents a $0.64 dividend on an annualized basis and a yield of 0.63%. Danaher’s dividend payout ratio is presently 15.88%.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.